{"id":12562,"date":"2026-08-14T18:50:02","date_gmt":"2026-08-14T18:50:02","guid":{"rendered":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/?p=12562"},"modified":"2026-08-14T19:07:33","modified_gmt":"2026-08-14T19:07:33","slug":"virtual-research-clinical-trials-quarterly-update-august","status":"publish","type":"post","link":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/","title":{"rendered":"Virtual Research &amp; Clinical Trials Quarterly Update &#8211; August"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-12563\" src=\"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-content\/uploads\/sites\/172\/2026\/08\/CTEV-Call-Blog-Post-Banner-1024x361.png\" alt=\"\" width=\"1024\" height=\"361\" srcset=\"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-content\/uploads\/sites\/172\/2026\/08\/CTEV-Call-Blog-Post-Banner-1024x361.png 1024w, https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-content\/uploads\/sites\/172\/2026\/08\/CTEV-Call-Blog-Post-Banner-300x106.png 300w, https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-content\/uploads\/sites\/172\/2026\/08\/CTEV-Call-Blog-Post-Banner-768x270.png 768w, https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-content\/uploads\/sites\/172\/2026\/08\/CTEV-Call-Blog-Post-Banner.png 1136w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/p>\n<p>Thank you to all who joined us on Thursday, August 13th! If you we\u2019re unable to make it, you can view the recording of the meeting here: \u00a0<a href=\"https:\/\/breakthrought1d-org.zoom.us\/rec\/share\/WQcowfUdtxUli0wl8i-M2mllaULefPq83RSQUChlJPdY5xBTNMh4QgslrCvWkc-0.ecw7Z8OUNFxpHUIy\" data-uw-rm-brl=\"PR\" data-uw-original-href=\"https:\/\/breakthrought1d-org.zoom.us\/rec\/share\/WQcowfUdtxUli0wl8i-M2mllaULefPq83RSQUChlJPdY5xBTNMh4QgslrCvWkc-0.ecw7Z8OUNFxpHUIy\"><strong>Pacific Northwest Research &amp; Clinical Trials Quarterly Update<\/strong><\/a><\/p>\n<h4>Contact your local CTEV!<\/h4>\n<p>If you have specific questions about clinical trials that might be fitting for you, or would like to get in contact with any of our speakers, please reach out to our Clinical Trial Education Volunteers (CTEV) below.<\/p>\n<h5>Oregon &amp; Washington:<\/h5>\n<p>Laura Tremblay, <a href=\"mailto:LDTremblay71@gmail.com\">LDTremblay71@gmail.com<\/a>,<\/p>\n<p>Jude Restis, JRestis@yahoo.com<\/p>\n<h4>Get Matched to a Clinical Trial in 60 Seconds<\/h4>\n<p><span class=\"TextRun SCXW213620417 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW213620417 BCX0\">To view local Pacific Northwest Clinical Trials, view our ongoing blog post with currently enrolling studies <a href=\"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/07\/24\/clinical-trials-and-studies-now-enrolling\/\">here<\/a>. Our<\/span><\/span><span class=\"EOP Selected SCXW91705795 BCX0\" data-ccp-props=\"{&quot;335559739&quot;:0}\">\u00a0<a href=\"https:\/\/antidote.me\/match\/search\/questions\/1?utm_source=jdrf_org&amp;utm_medium=trialmatch&amp;utm_campaign=unisearch&amp;width=auto&amp;height=360&amp;color=0073cf&amp;bg_color=ffffff&amp;diagnostic_area=diabetes&amp;partner=jdrf&amp;font=sans&amp;condition=Type%201%20Diabetes&amp;tr_uid=6ed9a987-3b22-4e72-9224-df3eb0415030.1676313670384&amp;referrer=https%253A%252F%252Fwww.jdrf.org%252Fimpact%252Fresearch%252Fclinical-trials%252F\"><strong>Clinical Trial Match Tool <\/strong><\/a>partnered with Antidote can also match you with clinical trials you might be eligible for\u2014all in under a minute!\u00a0<\/span><\/p>\n<h4>Subscribe to our Monthly Newsletter: The Pipeline<\/h4>\n<p><span class=\"TextRun SCXW213620417 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW213620417 BCX0\">Every month, Breakthrough T1D sends out <\/span><\/span><a class=\"Hyperlink SCXW213620417 BCX0\" href=\"https:\/\/www.breakthrought1d.org\/explore-research\/pipeline-sign-up\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span class=\"TextRun Underlined SCXW213620417 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW213620417 BCX0\" data-ccp-charstyle=\"Hyperlink\">The Pipeline<\/span><\/span><\/a><span class=\"TextRun SCXW213620417 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW213620417 BCX0\"> which is our monthly newsletter providing other various T1D research updates. You can subscribe to receive these <a href=\"https:\/\/www.breakthrought1d.org\/explore-research\/pipeline-sign-up\/\">here<\/a>.<\/span><\/span><\/p>\n<p>Thank you to all who attended the call &#8211; if you were not there, we&#8217;ll be holding these meetings quarterly, so we hope to see you at the next one! Stay up to date on when our next Quarterly Research &amp; Clinical Trials call will be on our <a href=\"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/#chapter-home-events\">events page<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Thank you to all who joined us on Thursday, August 13th! If you we\u2019re unable to make it, you can view the recording of the meeting here: \u00a0Pacific Northwest Research &amp; Clinical Trials Quarterly Update Contact your local CTEV! If&hellip;<\/p>\n","protected":false},"author":1194,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ep_exclude_from_search":false,"publish_on_app_meta":"True","iawp_total_views":24,"footnotes":"","_members_access_role":[],"_members_access_error":"","bt1d_storytelling_post":false,"bt1d_storytelling_more_posts":[]},"topics":[31,16,122],"class_list":["post-12562","post","type-post","status-publish","format-standard","hentry","jdrf_topic-clinical-trials","jdrf_topic-research","jdrf_topic-t1d-support"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Virtual Research &amp; Clinical Trials Quarterly Update - August - Oregon and Southwest Washington Chapter<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Virtual Research &amp; Clinical Trials Quarterly Update - August - Oregon and Southwest Washington Chapter\" \/>\n<meta property=\"og:description\" content=\"Thank you to all who joined us on Thursday, August 13th! If you we\u2019re unable to make it, you can view the recording of the meeting here: \u00a0Pacific Northwest Research &amp; Clinical Trials Quarterly Update Contact your local CTEV! If&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/\" \/>\n<meta property=\"og:site_name\" content=\"Oregon and Southwest Washington Chapter\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/breakthrought1dHQ\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-14T18:50:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-14T19:07:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-content\/uploads\/sites\/172\/2026\/08\/CTEV-Call-Blog-Post-Banner.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1136\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"aschuetze\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@breakthrought1d\" \/>\n<meta name=\"twitter:site\" content=\"@breakthrought1d\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"aschuetze\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/\"},\"author\":{\"name\":\"aschuetze\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/#\\\/schema\\\/person\\\/04faef1f03b1ecef42d1140e2916669c\"},\"headline\":\"Virtual Research &amp; Clinical Trials Quarterly Update &#8211; August\",\"datePublished\":\"2026-08-14T18:50:02+00:00\",\"dateModified\":\"2026-08-14T19:07:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/\"},\"wordCount\":235,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/wp-content\\\/uploads\\\/sites\\\/172\\\/2026\\\/08\\\/CTEV-Call-Blog-Post-Banner-1024x361.png\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/\",\"name\":\"Virtual Research &amp; Clinical Trials Quarterly Update - August - Oregon and Southwest Washington Chapter\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/wp-content\\\/uploads\\\/sites\\\/172\\\/2026\\\/08\\\/CTEV-Call-Blog-Post-Banner-1024x361.png\",\"datePublished\":\"2026-08-14T18:50:02+00:00\",\"dateModified\":\"2026-08-14T19:07:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/wp-content\\\/uploads\\\/sites\\\/172\\\/2026\\\/08\\\/CTEV-Call-Blog-Post-Banner.png\",\"contentUrl\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/wp-content\\\/uploads\\\/sites\\\/172\\\/2026\\\/08\\\/CTEV-Call-Blog-Post-Banner.png\",\"width\":1136,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/2026\\\/08\\\/14\\\/virtual-research-clinical-trials-quarterly-update-august\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Virtual Research &amp; Clinical Trials Quarterly Update &#8211; August\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/#website\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/\",\"name\":\"Oregon and Southwest Washington Chapter\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.breakthrought1d.org\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/BT1D-favi.png\",\"contentUrl\":\"https:\\\/\\\/www.breakthrought1d.org\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/BT1D-favi.png\",\"width\":400,\"height\":400,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/breakthrought1dHQ\",\"https:\\\/\\\/x.com\\\/breakthrought1d\",\"https:\\\/\\\/www.youtube.com\\\/@breakthrought1d\",\"https:\\\/\\\/www.instagram.com\\\/breakthrought1d\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@breakthrought1dhq\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.breakthrought1d.org\\\/oregonsouthwestwa\\\/#\\\/schema\\\/person\\\/04faef1f03b1ecef42d1140e2916669c\",\"name\":\"aschuetze\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4a4e563df15b9e17f112f2cb8deae37b48ec9dfbed813ad14407adbd8fa771c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4a4e563df15b9e17f112f2cb8deae37b48ec9dfbed813ad14407adbd8fa771c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4a4e563df15b9e17f112f2cb8deae37b48ec9dfbed813ad14407adbd8fa771c?s=96&d=mm&r=g\",\"caption\":\"aschuetze\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Virtual Research &amp; Clinical Trials Quarterly Update - August - Oregon and Southwest Washington Chapter","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/","og_locale":"en_US","og_type":"article","og_title":"Virtual Research &amp; Clinical Trials Quarterly Update - August - Oregon and Southwest Washington Chapter","og_description":"Thank you to all who joined us on Thursday, August 13th! If you we\u2019re unable to make it, you can view the recording of the meeting here: \u00a0Pacific Northwest Research &amp; Clinical Trials Quarterly Update Contact your local CTEV! If&hellip;","og_url":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/","og_site_name":"Oregon and Southwest Washington Chapter","article_publisher":"https:\/\/www.facebook.com\/breakthrought1dHQ","article_published_time":"2026-08-14T18:50:02+00:00","article_modified_time":"2026-08-14T19:07:33+00:00","og_image":[{"width":1136,"height":400,"url":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-content\/uploads\/sites\/172\/2026\/08\/CTEV-Call-Blog-Post-Banner.png","type":"image\/png"}],"author":"aschuetze","twitter_card":"summary_large_image","twitter_creator":"@breakthrought1d","twitter_site":"@breakthrought1d","twitter_misc":{"Written by":"aschuetze","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/#article","isPartOf":{"@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/"},"author":{"name":"aschuetze","@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/#\/schema\/person\/04faef1f03b1ecef42d1140e2916669c"},"headline":"Virtual Research &amp; Clinical Trials Quarterly Update &#8211; August","datePublished":"2026-08-14T18:50:02+00:00","dateModified":"2026-08-14T19:07:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/"},"wordCount":235,"commentCount":0,"publisher":{"@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/#organization"},"image":{"@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/#primaryimage"},"thumbnailUrl":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-content\/uploads\/sites\/172\/2026\/08\/CTEV-Call-Blog-Post-Banner-1024x361.png","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/","url":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/","name":"Virtual Research &amp; Clinical Trials Quarterly Update - August - Oregon and Southwest Washington Chapter","isPartOf":{"@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/#primaryimage"},"image":{"@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/#primaryimage"},"thumbnailUrl":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-content\/uploads\/sites\/172\/2026\/08\/CTEV-Call-Blog-Post-Banner-1024x361.png","datePublished":"2026-08-14T18:50:02+00:00","dateModified":"2026-08-14T19:07:33+00:00","breadcrumb":{"@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/#primaryimage","url":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-content\/uploads\/sites\/172\/2026\/08\/CTEV-Call-Blog-Post-Banner.png","contentUrl":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-content\/uploads\/sites\/172\/2026\/08\/CTEV-Call-Blog-Post-Banner.png","width":1136,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/2026\/08\/14\/virtual-research-clinical-trials-quarterly-update-august\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/"},{"@type":"ListItem","position":2,"name":"Virtual Research &amp; Clinical Trials Quarterly Update &#8211; August"}]},{"@type":"WebSite","@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/#website","url":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/","name":"Oregon and Southwest Washington Chapter","description":"","publisher":{"@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/#organization","name":"Breakthrough T1D","url":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/#\/schema\/logo\/image\/","url":"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BT1D-favi.png","contentUrl":"https:\/\/www.breakthrought1d.org\/wp-content\/uploads\/2024\/06\/BT1D-favi.png","width":400,"height":400,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/breakthrought1dHQ","https:\/\/x.com\/breakthrought1d","https:\/\/www.youtube.com\/@breakthrought1d","https:\/\/www.instagram.com\/breakthrought1d\/","https:\/\/www.tiktok.com\/@breakthrought1dhq"]},{"@type":"Person","@id":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/#\/schema\/person\/04faef1f03b1ecef42d1140e2916669c","name":"aschuetze","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f4a4e563df15b9e17f112f2cb8deae37b48ec9dfbed813ad14407adbd8fa771c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f4a4e563df15b9e17f112f2cb8deae37b48ec9dfbed813ad14407adbd8fa771c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f4a4e563df15b9e17f112f2cb8deae37b48ec9dfbed813ad14407adbd8fa771c?s=96&d=mm&r=g","caption":"aschuetze"}}]}},"_links":{"self":[{"href":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-json\/wp\/v2\/posts\/12562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-json\/wp\/v2\/users\/1194"}],"replies":[{"embeddable":true,"href":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-json\/wp\/v2\/comments?post=12562"}],"version-history":[{"count":0,"href":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-json\/wp\/v2\/posts\/12562\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-json\/wp\/v2\/media?parent=12562"}],"wp:term":[{"taxonomy":"jdrf_topic","embeddable":true,"href":"https:\/\/www.breakthrought1d.org\/oregonsouthwestwa\/wp-json\/wp\/v2\/topics?post=12562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}